Literature DB >> 629669

Vitrectomy for complications of diabetic retinopathy.

R G Michels.   

Abstract

Pars plana vitrectomy was used to treat 134 consecutive eyes with complications resulting from proliferative diabetic retinopathy, including nonabsorbing vitreous hemorrhage, recent traction and rhegmatogenous retinal detachment, progressive fibrovascular proliferation, and early rubeosis iridis with recent vitreous hemorrhage. Vision improved after surgery in 65% of the eyes, was unchanged in 16%, and decreased after surgery in 19%. In 24% of the successful cases, vision of 20/50 or better was achieved. When all posterior cortical vitreous was removed, no preretinal fibrovascular growth occurred after surgery. Nonatrophic epiretinal fibrovascular membranes that were not removed usually underwent centripetal contraction after surgery, causing tangential traction on the adjacent retina. Rubeosis iridis was the most common postoperative complication in otherwise successful cases, and rubeosis underwent regression after scatter retinal photocoagulation in some eyes.

Entities:  

Mesh:

Year:  1978        PMID: 629669     DOI: 10.1001/archopht.1978.03910050105001

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  23 in total

1.  Pathogenesis of proliferative neovascular retinopathies and the role of vitrectomy. A hypothesis.

Authors:  R Machemer
Journal:  Int Ophthalmol       Date:  1978-09       Impact factor: 2.031

2.  Experimental studies on the angiogenic activity of the detached retina.

Authors:  M Prost
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Primate model of neovascular glaucoma.

Authors:  A J Packer; X Q Gu; E G Servais; S S Hayreh
Journal:  Int Ophthalmol       Date:  1986-05       Impact factor: 2.031

4.  Abortive neovascular outgrowths discovered during vitrectomy for diabetic vitreous haemorrhage.

Authors:  H C Wong; K S Sehmi; D McLeod
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

5.  Factors influencing the results of vitreous surgery in diabetic retinopathy. I. Iris rubeosis and/or active neovascularization at the fundus.

Authors:  J Oldendoerp; M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

6.  Cryoapplication in diabetic retinopathy.

Authors:  A S Lim; B C Ang
Journal:  Int Ophthalmol       Date:  1986-05       Impact factor: 2.031

7.  Removal of silicone oil following diabetic vitrectomy.

Authors:  R V Pearson; D McLeod; Z J Gregor
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

8.  Ophthalmic survey of a diabetic clinic: II. Requirements for treatment of retinopathy.

Authors:  R H Grey; A Morris
Journal:  Br J Ophthalmol       Date:  1986-11       Impact factor: 4.638

9.  Ophthalmic survey of a diabetic clinic. I: Ocular findings.

Authors:  R H Grey; N Malcolm; D O'Reilly; A Morris
Journal:  Br J Ophthalmol       Date:  1986-11       Impact factor: 4.638

10.  Epiretinal membrane removal in diabetic eyes: comparison of viscodissection with conventional methods of membrane peeling.

Authors:  R A Grigorian; A Castellarin; R Fegan; C Seery; L V Del Priore; S Von Hagen; M A Zarbin
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.